119 related articles for article (PubMed ID: 32463097)
1. Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.
Akazawa R; Umeda K; Saida S; Kato I; Hiramatsu H; Sakamoto A; Arakawa Y; Sumiyoshi S; Okamoto T; Moritake H; Adachi S; Takita J
Jpn J Clin Oncol; 2020 Aug; 50(8):948-952. PubMed ID: 32463097
[TBL] [Abstract][Full Text] [Related]
2. Intensive Multimodal Therapy Combined With Long-term Temozolomide and Etoposide Treatment for Recurrent Osteosarcoma to the Liver and Stomach.
Umeda K; Taura K; Kato I; Saida S; Hiramatsu H; Shimizu H; Nakamoto Y; Uto M; Mizowaki T; Sakamoto A; Adachi S; Okamoto T; Takita J
J Pediatr Hematol Oncol; 2022 May; 44(4):175-177. PubMed ID: 35091520
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
Berger M; Grignani G; Ferrari S; Biasin E; Brach del Prever A; Aliberti S; Saglio F; Aglietta M; Fagioli F
Cancer; 2009 Jul; 115(13):2980-7. PubMed ID: 19452540
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.
Rodríguez-Galindo C; Daw NC; Kaste SC; Meyer WH; Dome JS; Pappo AS; Rao BN; Pratt CB
J Pediatr Hematol Oncol; 2002 May; 24(4):250-5. PubMed ID: 11972091
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
Worth LL; Jaffe N; Benjamin RS; Papadopoulos NE; Patel S; Raymond AK; Jia SF; Rodriguez C; Gano J; Gianan MA; Kleinerman ES
Clin Cancer Res; 1997 Oct; 3(10):1721-9. PubMed ID: 9815556
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
Fagioli F; Aglietta M; Tienghi A; Ferrari S; Brach del Prever A; Vassallo E; Palmero A; Biasin E; Bacci G; Picci P; Madon E
J Clin Oncol; 2002 Apr; 20(8):2150-6. PubMed ID: 11956277
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Rocca M; Ferrari S; Donati D; Longhi A; Bertoni F; Bacchini P; Giacomini S; Forni C; Manfrini M; Galletti S
Ann Oncol; 2003 Jul; 14(7):1126-34. PubMed ID: 12853357
[TBL] [Abstract][Full Text] [Related]
8. Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults.
Ju HY; Park M; Lee JA; Park HJ; Park SY; Kim JH; Kang HG; Yang HC; Park BK
Cancer Res Treat; 2022 Apr; 54(2):563-571. PubMed ID: 34126703
[TBL] [Abstract][Full Text] [Related]
9. [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Hirota T; Takeuchi M; Iwata A; Kitagawa S; Sato T; Konno K; Sawada K; Kobayashi S; Hamaguchi N; Agata H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):385-90. PubMed ID: 9492832
[TBL] [Abstract][Full Text] [Related]
10. OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.
Gaspar N; Campbell-Hewson Q; Huang J; Okpara CE; Bautista F
Future Oncol; 2021 Nov; 17(32):4249-4261. PubMed ID: 34382412
[TBL] [Abstract][Full Text] [Related]
11. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Schwartz S; Szeto C; Tian Y; Cecchi F; Corallo S; Calegari MA; Di Bartolomeo M; Morano F; Raimondi A; Fucà G; Martinetti A; De Pascalis I; Martini M; Belfiore A; Milione M; Orlandi A; Barault L; Barone C; de Braud F; Di Nicolantonio F; Benz S; Hembrough T; Pietrantonio F
Eur J Cancer; 2019 Jan; 107():164-174. PubMed ID: 30579113
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
[TBL] [Abstract][Full Text] [Related]
13. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan and temozolomide chemotherapy in paediatric and adult populations with relapsed Ewing Sarcoma.
Salah S; To YH; Khozouz O; Ismail T; Yaser S; Alnsour A; Shahin O; Sultan I; Abuhijlih R; Halalsheh H; Abuhijla F; Lewin J
Clin Transl Oncol; 2021 Apr; 23(4):757-763. PubMed ID: 32761317
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
Younis SG; Khedr RA; El-Shorbagy SH
J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
[TBL] [Abstract][Full Text] [Related]
18. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
Cassano WF; Graham-Pole J; Dickson N
Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
[TBL] [Abstract][Full Text] [Related]
19. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
Büyükkapu Bay S; Kebudi R; Görgün O; Zülfikar B; Darendeliler E; Çakır FB
J Oncol Pharm Pract; 2019 Sep; 25(6):1343-1348. PubMed ID: 30080131
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Machak GN; Polotskiĭ BE; Meluzova OM; Chernov IS; Aliev MD
Vopr Onkol; 2010; 56(2):220-5. PubMed ID: 20552902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]